We are live on
!
Find out more
PCA
Private Capital Advisors Portfolio holdings
AUM
$1.15B
Turnover
18.82%
1-Year Est. Return
43.46%
This Fund
S&P 500
This Quarter
Est. Return
+5.13%
1 Year Est. Return
+43.46%
3 Year Est. Return
+131.91%
5 Year Est. Return
+229.29%
10 Year Est. Return
+757.55%
AUM
$319M
AUM Growth
+$18.9M
(+6.3%)
Cap. Flow
+$6.94M
Cap. Flow
% of AUM
2.17%
Top 10 Holdings %
Top 10 Hldgs %
37.77%
Holding
106
New
6
Increased
17
Reduced
26
Closed
10
Avg Time Held
3.1
years
Top 10 Avg Time Held
1.3
years
Top 20 Avg Time Held
1.9
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Karyopharm Therapeutics
KPTI
|
+$6.87M |
| 2 |
IBM
IBM
|
+$6.33M |
| 3 |
Jazz Pharmaceuticals
JAZZ
|
+$3.96M |
| 4 |
Stryker
SYK
|
+$2.76M |
| 5 |
Cigna
CI
|
+$2.33M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$3.67M |
| 2 |
ARMO
ARMO BioSciences, Inc. Common Stock
ARMO
|
+$1.74M |
| 3 |
iShares Biotechnology ETF
IBB
|
+$1.38M |
| 4 |
KKR & Co
KKR
|
+$1.27M |
| 5 |
Targa Resources
TRGP
|
+$841K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 31.66% |
| 2 | Technology | 16.82% |
| 3 | Communication Services | 16.5% |
| 4 | Industrials | 8.67% |
| 5 | Miscellaneous | 6.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
76
Ladder Capital
LADR
$1.16B
| $273K | 0.09% |
+17,500
| New | +$263K |
2018 Q2
0 quarters
|
|
77
State Street SPDR S&P 500 ETF Trust
SPY
$806B
| $264K | 0.08% |
973
| – | – |
2017 Q4
2 quarters
|
|
78
DELISTED
R1 RCM Inc. Common Stock
RCM
| $260K | 0.08% |
30,000
| – | – |
2017 Q3
3 quarters
|
|
79
State Street Technology Select Sector SPDR ETF
XLK
$121B
| $252K | 0.08% |
7,242
| – | – |
2017 Q4
2 quarters
|
|
80
Berkshire Hathaway Class B
BRK.B
$1.14T
| $243K | 0.08% |
1,300
| – | – |
2014 Q3
15 quarters
|
|
81
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
| $241K | 0.08% |
7,405
| – | – |
2016 Q2
8 quarters
|
|
82
DuPont de Nemours
DD
$17.6B
| $228K | 0.07% |
1,366
| – | – |
2017 Q3
3 quarters
|
|
83
TJX Companies
TJX
$162B
| $228K | 0.07% |
+4,800
| New | +$211K |
2018 Q2
0 quarters
|
|
84
Alibaba
BABA
$271B
| $218K | 0.07% |
1,175
-235
| -17% | -$44.8K |
2017 Q3
3 quarters
|
|
85
SiriusXM
SIRI
$9.09B
| $116K | 0.04% |
1,721
+449
| +35% | +$30.3K |
2016 Q2
8 quarters
|
|
86
ProShares Ultra NASDAQ Biotechnology
BIB
$88.3M
| – | – |
-10,000
| Closed | -$551K | – |
|
87
BioMarin Pharmaceuticals
BMRN
$10.6B
| – | – |
-10,000
| Closed | -$811K | – |
|
88
Neighborhood Intelligence Inc
NXH
$172M
| – | – |
-14,356
| Closed | -$391K | – |
|
|
89
KKR & Co
KKR
$77.4B
| – | – |
-62,479
| Closed | -$1.27M | – |
|
90
Lam Research
LRCX
$330B
| – | – |
-20,750
| Closed | -$422K | – |
|
|
91
Targa Resources
TRGP
$63.2B
| – | – |
-19,122
| Closed | -$841K | – |
|
92
Verastem
VSTM
$783M
| – | – |
-15,704
| Closed | -$562K | – |
|
93
JOYY Inc
JOYY
$4.05B
| – | – |
-3,000
| Closed | -$316K | – |
|
|
ARMO
94
DELISTED
ARMO BioSciences, Inc. Common Stock
ARMO
| – | – |
-46,574
| Closed | -$1.74M | – |
|
Similar funds
WB
AIC
CFP
HT
AA
CIG
CIS
FWM
Private Capital Advisors's Q2 2018 Portfolio in Review
As of Q2 2018, Private Capital Advisors held 106 positions worth $319M, up 6.3% from $300M the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Private Capital Advisors's Q2 2018 filing shows 6 new, 17 increased, 26 reduced and 10 closed positions. Its largest new stake was Karyopharm Therapeutics: 27,793 shares worth $7.08M. The largest sale was Meta Platforms (Facebook), an estimated $3.67M.
By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 27% a quarter earlier, followed by Technology and Communication Services.
- Private Capital Advisors's largest Q2 2018 buy was Karyopharm Therapeutics: 27,793 shares worth $7.08M.
- Private Capital Advisors added most to IBM in Q2 2018, an estimated $6.33M increase.
- Private Capital Advisors's biggest Q2 2018 reduction was Meta Platforms (Facebook), cutting an estimated $3.67M.
- Private Capital Advisors fully exited ARMO BioSciences, Inc. Common Stock in Q2 2018, selling an estimated $1.74M.
- Private Capital Advisors's ten largest holdings make up 38% of its $319M portfolio in Q2 2018.
- Private Capital Advisors opened 6 new positions and closed 10 in Q2 2018.
- Private Capital Advisors's portfolio value rose 6.3% quarter-over-quarter to $319M.
Based on Private Capital Advisors's 13F filing for Q2 2018, filed 10 Jul 2018.